Digital Health News | pharmaphorum

Friday 16 October 2026

News

News

AI in drug discovery & development: News watch, October 2026

AI in drug discovery & development: News watch, October 2026

Recent news in biopharma AI include a $1.5bn partnership between AstraZeneca and insitro, plus news from Iambic, DaltonTx, NVIDIA, and Chai Discovery.

News

MHRA Strategy doc

MHRA lays out its thinking on AI and medicines regulation

An MHRA document explaining how regulations will adapt to the era of AI and personalised medicine has been well received by the pharma industry.

News

Zealand Pharma and Generate Biomedicines logos on light blue background

Zealand forges obesity alliance with AI specialist Generate

Zealand has added another strand to its programme of weight-loss drug development, linking with AI player Generate on multispecific protein therapies.

News

AIxBio event

Biohub raises $1.8bn for its 'virtual biology' initiative

Just months after launching an open-source 'virtual biology' platform, Biohub has raised $1.8 billion in backing for the AI-powered initiative.

News

Click's Motivista for schizophrenia

Click claims FDA okay for first-in-class schizophrenia DTx

Click Therapeutics has won the first-ever FDA approval for a treatment for the negative symptoms of schizophrenia, a DTx called Motivista.

News

HCP checks through AI in healthcare

UK backs all health AI proposals in commission report

The UK will accept all 44 proposals made in a recent report on using AI tools in the NHS, including continuous monitoring after deployment.